CRBP Latest Headlines

Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP) and Korro Bio (KRRO)

at www.tipranks.com (Fri, 7-Aug 9:50 PM)

Corbus Buy Rating Reaffirmed as Advancing Pipeline and Upcoming Catalysts Support Upside with Unchanged $38 Price Target

at www.tipranks.com (Fri, 7-Aug 2:55 PM)

Analysts Are Bullish on Top Healthcare Stocks: Corbus Pharmaceuticals (CRBP), Intellia Therapeutics (NTLA)

at www.tipranks.com (Fri, 7-Aug 6:50 AM)

Wall Street Analysts Are Bullish on Top Healthcare Picks

at www.tipranks.com (Thu, 6-Aug 9:30 PM)

Corbus Highlights Wider Loss and Strengthened Liquidity Position

at www.tipranks.com (Thu, 6-Aug 8:54 AM)

Corbus Pharmaceuticals GAAP EPS of -$1.81

at seekingalpha.com (Thu, 6-Aug 8:05 AM)

CRB-701 Shows Strong Clinical Activity and Tolerability in Oropharyngeal and Cervical Cancer Phase 1/2 Trial

Market Chameleon (Tue, 26-May 7:06 AM)

Corbus Pharmaceuticals Prepares for Major Investor Conferences as Focus Shifts to Oncology and Obesity Pipeline

Market Chameleon (Thu, 14-May 11:44 AM)